Omeros (OMER) EBIT Margin (QoQ) (2010 - 2021)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Omeros | 772.03 Mn | 636.71 Mn | 9.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | 2,550.00 |
| Jun 30, 2021 | 5,680.00 |
| Mar 31, 2021 | 10,302.00 |
| Dec 31, 2020 | -22,069.00 |
| Sep 30, 2020 | 10,721.00 |
| Jun 30, 2020 | -10,399.00 |
| Mar 31, 2020 | -2,966.00 |
| Dec 31, 2019 | -3,375.00 |
| Sep 30, 2019 | -228.00 |
| Jun 30, 2019 | 5,343.00 |
| Mar 31, 2019 | -443.00 |
| Dec 31, 2018 | 68,523.00 |
| Sep 30, 2018 | 108,083.00 |
| Jun 30, 2018 | -10,633.00 |
| Mar 31, 2018 | -164,102.00 |
| Dec 31, 2017 | -7,903.00 |
| Sep 30, 2017 | 4,602.00 |
| Jun 30, 2017 | 3,421.00 |
| Mar 31, 2017 | -1,194.00 |
| Dec 31, 2016 | 1,476.00 |
| Sep 30, 2016 | 261.00 |
| Jun 30, 2016 | 15,295.00 |
| Mar 31, 2016 | 807.00 |
| Dec 31, 2015 | 32,197.00 |
| Sep 30, 2015 | -9,123.00 |
| Jun 30, 2015 | 412,013.00 |
| Mar 31, 2015 | 647,609.00 |
| Dec 31, 2014 | -309,161.00 |
| Sep 30, 2014 | 3.03 Mn |
| Jun 30, 2014 | -2.26 Mn |
| Mar 31, 2014 | -745,796.00 |
| Dec 31, 2013 | -137,195.00 |
| Sep 30, 2013 | 254,592.00 |
| Jun 30, 2013 | -848,493.00 |
| Mar 31, 2013 | -43,920.00 |
| Dec 31, 2012 | 44,410.00 |
| Sep 30, 2012 | -37,974.00 |
| Jun 30, 2012 | -66.00 |
| Mar 31, 2012 | 32,193.00 |
| Dec 31, 2011 | -23,699.00 |
| Sep 30, 2011 | -19,603.00 |
| Jun 30, 2011 | 9,210.00 |
| Mar 31, 2011 | 35,616.00 |
| Dec 31, 2010 | 207,208.00 |
| Sep 30, 2010 | -141,280.00 |